International Journal of Technology Assessment in Health Care

Article	Citations
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	173
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder	31
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”	25
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries	20
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy	19
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis	18
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service	17
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses	17
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis	17
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands	16
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management	16
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation	15
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets	15
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective	15
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride	15
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 1	13
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation	13
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation	12
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study	12
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement	11
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization	11
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease	11
Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury	10
PD129 Extension Of An Influenza Vaccination Program To Include Those Aged 50 To 64 Years: A Rapid Health Technology Assessment Approach	9
PP56 National Immunization Technical Advisory Groups Are Essential For Successful Implementation Of The European Health Technology Assessment Regulation	9

OP76 Cost-Effectiveness Of Offering Human Papillomavirus Self-Sampling To Non-Attendees Of Organized Primary Cervical Cancer Screening In Germany	9
PD149 Comparison Of The Draft European Union Health Technology Assessment Template With Germany’s AMNOG Template	9
OD12 Large Language Models As Powerful Tools In Health Technology Assessment	8
OP25 Rapid Molecular Tests For Detecting Multidrug-Resistant Microorganisms: An Overview Of Systematic Reviews Within A Living Evidence Project	8
PP07 One Bad Apple Can Spoil The Barrel: Are We Effectively Evaluating Software As A Medical Device?	8
PD137 Reviewing The Health Technology Assessment And Regulatory Policy Landscape On Acceptability Standards For Real-World Evidence - Initial Findings	8
PD10 Cost Effectiveness Analysis Of Etranacogene Dezaparvovec Versus Factor IX Prophylaxis In Adult Men With Hemophilia B From Brazil	8
PP92 Enhancing Patient Engagement In Health Technology Assessment: Identification Of Barriers, Facilitators, And Proposals For Improvement	8
Development and Implementation of a Value Framework for Rapid Health Technology Assessment Reports: Enhancing Evidence-Informed Decision Making in Resource-Constrained Settings	7
PD208 Optimal Scheme For Molecular Diagnosis Of BRCA1/2 Gene Mutations In Patients With Breast Cancer In Poland - Cost-Utility Analysis	7
Methods and criteria for the assessment of orphan drugs: a scoping review	7
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	7
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture	7
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	7
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report	7
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	6
PP149 A Multidimensional And Multistakeholder Approach: Assessing Ethical, Legal, Organizational, Social or Patient-centered (ELSI+) for Telemedicine In Neurological Diseases	6
Acknowledgments	6
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	6
OP90 Optimizing Health Technology Assessment And Appraisal For Orphan Drug Reimbursement: Experiences And Tools For Improvement	6
PP165 Bridging The Gap Of Health Services During The COVID-19 Pandemic Through Telemedicine	6
Mapping frameworks for synthesizing qualitative evidence in health technology assessment	6
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum	6
PP09 Use Of Real-World Evidence For Managing Health Technologies Throughout The Life Cycle Of Transcatheter Aortic Valve Interventions	6
PP118 Cyclic Mental Health Technology Assessment with Priority Setting And Involving Stakeholders - A Case Report From The Netherlands	6
Results of health technology assessments of orphan drugs in Germany—lack of added benefit, evidence gaps, and persisting unmet medical needs	5
PP146 Seeing Eye-To-Eye on Real-World Evidence: Are Guidance from Japan and China Consistent with Recommendations from REALISE in Asia?	5
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative study	5
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	5
PP259 Invisible Resilience: The Value Of Medical Technology In Reducing Population And Health Systems’ Vulnerability To COVID-19.	5
OP27 Impact Of Generic Entry Of Pharmaceuticals On Drug Prices In Australia	5
OP167 An Analysis Of Medication Exclusion Reports In The Health Technology Assessment Process For The Brazilian Unified Health System	5
OP126 Clinical And Economic Evaluation Of The Effectiveness Of Cerebrolysin® In Neurological Patients With Post-Stroke Complications In Kazakhstan	5
OP181 Adapting Evidence To Produce A Health Technology Assessment Of Mammography Screening: An Example From The West Bank	5
OP46 The Decision Uncertainty Toolkit: Risk Measures And Visual Outputs To Support Health Technology Decision-making During Public Health Crises	5
OP129 The Use Of A Text-Mining Screening Tool For Systematic Review Of Treatments For Relapsed/Refractory Diffuse Large B-Cell Lymphoma	5
PP09 Fecal Immunochemical Tests For Patients With Symptoms Suggestive Of Colorectal Cancer: A Systematic Review And Multiple-Threshold Meta-Analysis	4
Economic evaluation of genomic/genetic tests: a review and future directions	4
OP176 Integrating Real-world Compliance In The Assessment Of Left Atrial Appendage Closure Versus Anticoagulation Therapy In Non-valvular Atrial Fibrillation	4
OD11 Application Of Natural Language Processing To Predict Final Recommendation Of Brazilian Health Technology Assessment Reports	4
The role of health economics within health technology assessment: past, present, and future – an Austrian perspective	4
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	4
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	4
Use of surrogate endpoints in health technology assessment: a review of selected NICE technology appraisals in oncology	4
Health technology assessment and healthcare environmental sustainability: Prioritizing effort and maximizing impact	4
PD203 Comparison Of Health Technology Assessment Methodologies Across Australia, Canada, New Zealand And The United Kingdom: Implications For Future Collaboration	4
PD71 Survival Outcomes And Adherence To Defined Daily Doses Of Imiglucerase: A 16-Year Brazilian Cohort Study In Gaucher Disease	4
A first exploration of the economic consequences of an autonomous surgical robot for lateral skull base surgery: an early health technology assessment	4
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	4
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	4

Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	4
A review of HTA guidelines on societal and novel value elements	4
OP80 Generating Patient Preference Evidence For Health Technology Assessment: A Sustainable Roadmap	4
The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey	4
Acceptability of Manufacturer-Proposed Utility Values for NICE Cancer Medicine Appraisals: Analysis of Manufacturers’ Information Sources	4
A value framework for lymphoma therapies based on MACBETH method	4
PP70 Mapping Of Health Technology Assessment In China: A Comparative Study Between 2016 And 2021	3
PD22 Exploratory Analysis of a Brazilian Real-World Open Database Applied to Prostate Cancer	3
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	3
PD42 Should Antibiotics Be Used To Treat Recurrent Otitis Media In Children? Updating A Recommendation	3
PP55 Health Technology Assessment Scoping Definition For Health Regulation	3
Patient perspectives on continuous glucose monitoring system (CGMS) for diabetes in Malaysia: a vital voice in health technology assessment (HTA) informing decision-making	3
OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project	3
PP275 Incorporating Quality-Of-Care Indicators In Health Economic Modelling: A Case-Study On Surgical Site Infections In Cardiac Surgery	3
OP163 Applying A Local Economic Evaluation Framework To Make Evaluations More Relevant For Local Decision Makers	3
PP195 Cost Utility Of Transcatheter Aortic Valve Implantation For Patients With Inoperable Severe Aortic Stenosis In Brazil	3
OP51 Use Of Real-World Data In Cost-effectiveness Analysis Of Sequential Biologic Treatment For Rheumatoid Arthritis	3
OP65 An Overview Of Participatory Approaches, Stakeholders, Methods, Topics and Challenges In Medical Device Development: A Scoping Review	3
PP34 Impact Of The COVID-19 Pandemic On Depression Incidence And Healthcare Service Use Among Patients With Depression	3
PD124 Genicular Artery Embolization For The Treatment Of Knee Osteoarthritis: A Systematic Review And Meta-analysis	3
PP111 Reimbursement And Payment Models: A Survey Of Stakeholders’ Current Experiences And Future Outlook Within The Dutch Policy Setting	3
PD05 Novel Non-Thermal Ablation Technology For The Treatment Of Atrial Fibrillation	3
Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines	3
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	3
OP199 From Pilot Studies To System-Wide Innovation: Challenges And Opportunities For Clinical Decision Support Systems (CDSS) Implementation In Australia	3
OP44 Does The Health Economic Modelling Structure Matter? An External Validation Of Three Approaches Commonly Used In Obesity Modelling	3
OP01 Impact Of Cost Heterogeneity On Assessing The Value Of Gene Therapies	3
OP105 Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment	3
Optimizing red blood cell transfusion practices in the intensive care unit: a multi-phased health technology reassessment	3
PD231 A New Way Of Identifying And Selecting Health Technology Assessment Topics: Using Social Media And Citizen Involvement	3
PP57 Outcomes Model For Assessing Strategies Improving In Vitro Fertilization Birth Rates	3
Acceptability of self-administered antigen test for COVID-19 in the Philippines	3
OP136 A Comparison Of Health Technology Assessment Recommendations In Australia, Canada, And England: Is There Opportunity For Further Alignment?	3
PD177 The Effect Of COVID-19 On Cancer Screening In Brazil, Canada, And The USA: A Cross-National Study	2
PD133 Exploring Real-World Data Based Financing Models For Lung Cancer Immunotherapy In The Czech Republic	2
PP33 Molecular Markers For The Detection Of Clinically Significant Prostate Cancer	2
Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape	2
PP109 Which Review Is Right For You? Choosing A Review Methodology	2
OP13 Improving Case Finding For Celiac Disease In Children And Adults: Evidence Synthesis And Economic Modeling	2
OP31 Monitoring Of The Budget Impact Determinants Of Incorporated Technologies For Rare Diseases In The Brazilian Health System	2
OP279 Data Protection In The European Union Post-General Data Protection Regulation (GDPR): A Barrier Or An Enabler Of Pharmaceutical Innovation?	2
PP129 Health Technology Assessment Adaptation: Pharyngolaryngeal Biopsies (OLB) For People with Suspected Head and Neck Cancer in the Outpatient Setting	2
Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA	2
OD33 Assessment Tool For MHealth Apps To Manage Depression (EvalDepApps Project)	2
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	2
OP70 Implementation Of An Online Consultation Hub To Facilitate Consumer Engagement In Health Technology Assessment Processes	2
PP37 Guidance On Using Hospital-Based Real-World Evidence In Health Technology Assessments For Oncology	2
OP244 Tools And Experiences To Facilitate Effective Patient Participation In Health Technology Assessment	2
PD60 The Importance Of Systematic Reviews Addressing Questions Of Prevalence In Health Technology Assessment	2
Lifecycle evaluation of medical devices: supporting or jeopardizing patient outcomes? A comparative analysis of evaluation models	2
PD61 Thromboprophylaxis After Major Orthopedic Surgeries: Health Technology Assessment To Promote Access To Oral Anticoagulants	2
PD119 Interventions To Improve Long COVID Symptoms: A Systematic Review Of Randomized Controlled Trials	2
PD50 Does The New Healthcare Reform Improve Job Satisfaction Among Village Clinic Doctors In China? A Meta-Analysis	2
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	2
OP79 Incorporating Environmental Impacts Into Health Technology Assessment: An Examination Of Potential Approaches And Challenges	2
Building Capacity in Horizon Scanning, Early Awareness, and Disinvestment: A Framework for Education and Training	2
Analysis of consumer comments into PBAC decision-making (2014–9)	2
OD39 Evaluation Of Sustainability And Environmental Impact Measures In Health Technology Assessment Of Medical Technologies In Europe: Starting An Important Journey	2
PD186 Treat-To-Target In Gout: Are Private General Practitioners In Malaysia Riding The Evidence-Based Wave?	2
A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK	2
PD07 Cost-Effectiveness Of Direct Oral Anticoagulants In Chinese Patients With Non-Valvular Atrial Fibrillation	2
PP120 Fluorescent In Situ Hybridization (FISH) Vs Conventional Cytogenetic (CC) For Detecting High-Risk Genetic Mutations In Multiple Myeloma	2
OD30 Clinician-Driven Health Technology Assessment: National Cancer Medicines Review For Off-Label Uses And On-Label Off-Patent Uses In NHSScotland	2
PP53 Potential Cost-Effectiveness And Innovation Headroom Of A More Accurate Companion Diagnostic For PD-L1 In Non-Small-Cell Lung Cancer	2
PP87 Glecaprevir/pibrentasvir (Maviret®) Remains A Cost-effective Treatment For Chronic Hepatitis C Virus Infection After Changes To The Treated Population	2
PP222 Efficacy And Safety Of Foot Reflexology	2
PP41 COVID-19 Modeling To Support Decision Making In Brazil: A Scoping Review	2
Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum	2
PD199 Global Collaboration Post-Brexit: Do Project Orbis And The Access Consortium Improve Access In The UK Compared With Europe?	2
OP98 Improving Patient Involvement In Health Technology Assessments: Is It Enough To Train Just The Patients?	1
PD18 Cytomegalovirus Prophylaxis With Valganciclovir For HIV-Immunosuppressed Patients: Cost Effectiveness And Budget Impact Analysis From The Brazilian Healthcare System Perspective	1
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care	1
OD17 Future Health And Economic Burden Of Cardiovascular Disease In Type 2 Diabetes In Australia From 2021 To 2031	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
OP67 Considerations Of Treatment Novelty In Health Technology Assessment	1
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report	1
INAHTA member agency stories of engaging, adaptable, and impactful HTA	1
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review	1
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	1
OP88 Translating Patient Reported Measure Score Into Specific Outcomes From The Patient Perspective–Example Using Health Assessment Questionnaire-Disability Index	1

Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review	1
PD185 Is The Incorporation Of Medications For Ultrarare Diseases In Brazil Predominantly Driven By Costs? A Shift In Paradigm	1
OP11 Differences And Similarities In Past Health Technology Assessments In Beneluxa Initiative Countries	1
PP59 Do Patient Contributions Matter? A Thematic Document Analysis Of NICE Ultra-Rare Disease Appraisals	1
OP93 Informing Efficient Diagnostic Monitoring Pathways Using Prospective Cohort Data: A Case Study In Neovascular Age-Related Macular Degeneration	1
PD90 Use Of Medicinal Herbs In Natura By Pregnant Women In The Amazon Region	1
OP47 New Health Technology Assessment Framework For Digital Health Technologies	1
OP69 Are Artificial-Intelligence-Based Literature Reviews Accepted By Health Technology Assessment Bodies?	1
OP172 International Collaboration For Translating The Peer Review Of Electronic Search Strategies (PRESS) Checklist: A Harmonized Approach	1
PD93 Uncertainty Metric To Guide PICOS Assessment And Evidence Synthesis Planning For Joint Clinical Assessment Submission	1
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia	1
PD25 Innovation In Facial Palsy Treatment: The Costs And Benefits Of Telerehabilitation Introduced Into Physical Therapy Pathways	1
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain	1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets	1
PP153 Efficacy And Safety of Onasemnogene Abeparvovec For The Treatment Of Patients With Spinal Muscular Atrophy Type 1: Meta-Analysis	1
OD26 Comparing Health Technology Developers’ Proposed Indication To An Estimated Indication Generated By An International Horizon Scanning Database	1
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions	1
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience	1
PP12 Challenges In Assessing The Efficacy Of Non-Pharmacological Measures In The Context Of The COVID-19 Pandemic	1
OD37 How The PICOTS-ComTeC Framework For Digital Health Interventions Can Be Useful For Health Technology Assessment	1
OP83 Diagnostic Accuracy And Cost Effectiveness Of Automated Ankle Brachial Pressure Index Measurement For Peripheral Arterial Disease In People With Leg Ulceration	1
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations	1
OP45 Incorporation Of The Tetravalent Dengue Vaccine In The Brazilian Public Health System: A Cost–Benefit Analysis	1
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	1
PP219 Combining Healthcare Solutions For Cataract Surgery. An Incremental Benefit Analysis From The Perspective Of The Russian Healthcare System	1
OP11 Cost-Effectiveness Of Atezolizumab Plus Chemotherapy As A First-Line Treatment For Metastatic Non-Squamous Non-Small Cell Lung Cancer	1
Health technology assessment for oral health in the past decade: a scoping review	1
PD173 Semi-Automation Of Systematic Literature Review Title And Abstract Screening Using Text Mining And Classification Techniques	1
PP13 Development Of Recommendations And Proposal For A Value-Based Managed Entry Agreement For Italian Setting	1
PD32 Incorporating Environmental Factors Into Health Technology Assessment Submissions: A Scoping Review	1
OP35 Suitability Of Preference Methods Across The Medical Product Lifecycle: A Multicriteria Decision Analysis	1
PP43 Budget Impact Analysis Of Next-Generation Sequencing Coverage In Taiwan’s National Health Insurance	1
OP61 Target Trial Emulation To Determine The Population-Level Cost-Effectiveness Of Multigene Panel Sequencing For Advanced Melanoma	1
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device	1
Expanding access to sodium-glucose cotransporter 2 inhibitors (SGLT2i) in the Ministry of Health Malaysia – a multiple HTA approach	1
PD116 Development Of A Value Framework For The Appropriate Prescription Of High-Cost Cancer Drugs In A Cancer Center	1
Implementing a sandbox approach in health technology assessment: benefits and recommendations	1
PP21 Examining Clinical Evidence: Incorporation Of Medications For Ultra-Rare Diseases – Descriptive Analysis Of Conitec Reports (2012 to 2022) – Brazil	1
OP74 Analysis Of Literature And Research Foci In Overdiagnosis Based On Citespace	1
National health technology assessment in Turkiye after a decade: are key principles followed?	1
PD56 Conceptual Issues In The Valuation Of Health States In Children	1
OP168 Costs And Effectiveness Of Whole Exome Sequencing (WES) In Patients With Unsolved Rare Disease Through The Diagnostic Pathway	1
PD155 RedETS Horizon Scanning: Impact In The Decision-Making Process	1
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group	1
PP84 Evaluation Of The Evidence Level Of Scrambler Therapy For Musculoskeletal Pain Relief: A Systematic Literature Review	1
OD41 Conducting Systematic Reviews On Rare Diseases: Lessons Learned From The European Reference Networks Guidelines Programme	1
PD35 A Decade In Review: Assessing The Quality Of Clinical Evidence For Oncology Drugs Submitted To A National Health Technology Assessment Agency	1
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	1
OP102 Towards Universal Health Coverage: Health Technology Assessment Roadmap Development In The Emirate Of Abu Dhabi Involving The Whole Ecosystem	1
Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting	1
OP35 Early Access To Medicinal Products In France: A Positive Evaluation Two Years Into The New Framework	1
OP316 Patients’ Testimonials In The National Committee For Health Technology Incorporation In Brazilian Public Health System (Conitec) Meetings	1
OP51 Improving Childhood Cancer Management And Financing In Ghana: Results From Stakeholder Mapping and Analysis	1
OP43 Incorporating Mathematical Modeling To Improve Accuracy Of Budget Impact Analysis: Using Screening For Hepatitis C As An Example	1
PP153 The Economic And Fiscal Impact Of Public Health Programs For Diabetic Patients In Italy	1
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil	1
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France	1
PP100 Improving The Assessment Of Effectiveness For Digital Applications Using The B Statistic: Using WtsWrng As A Case Study	1
OP56 Hospital-Based Health Technology Assessment: Barriers And Facilitators In France, Hungary, Italy, Kazakhstan, Poland, Switzerland, And Ukraine	1
PD96 Are Continuous Noninvasive Blood Pressure Monitoring Devices Accurate Enough To Replace Invasive Monitoring? A Rapid Review	1
The relative importance of severity and rarity criteria in health resource allocation: an umbrella review	1
PP63 Perspectives Of Physical And Organic Disability Organizations On Health Technology Assessment Processes	1
Response to heterogeneity of tests and platforms in economic evaluations: synthetic model adoption; derivatives of transferable practice	1
PP24 Creating A Comprehensive Open-Access Health Technology Assessment (HTA) Policy Research Database Through Automated Data Extraction From HTA Reports	1
Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature	0
International overview of health technology assessment training tools and materials for patients and consumers	0
OP71 Patient Disease Strategy: A New Operational Framework For Collecting And Applying Patient Experience Data Into Clinical Development Programs	0
OD44 Consolidated Health Economic Evaluation Reporting Standards For Interventions That Use Artificial Intelligence (CHEERS-AI)	0
PD01 Using ELISA Tests For Monitoring Response To Anti-TNFs In Rheumatoid Arthritis: Findings From A NICE Health Technology Assessment	0
PP44 Time Is Now: Advancing Value Assessment Of Cancer Therapies To Help Eliminate Cancer As The Cause Of Death	0
Perceptions of patients and caregivers toward the management of rare disease in Malaysia: a qualitative research study	0
Early access schemes for innovative health technologies: the views of international stakeholders	0
PD59 Review Of The International Epidemiology Of Long COVID	0
PP62 Improving Patients’ Access To Medicines Through Health Technology Assessment In Ukraine: Measuring The Impact Of The National HTA Roadmap	0
Health technology assessment (HTA) readiness in Uganda: stakeholder’s perceptions on the potential application of HTA to support national universal health coverage efforts	0
HTA capacity building in Asia: towards one goal	0
PD43 Single-Arm Studies In Literature Reviews: Trials Versus Case Series	0
OP79 Innovations In Measuring And Valuing Outcomes: Generating Preferences For The EQ Health And Wellbeing Short	0
PD29 Systematic Review With Meta-analysis Of Pharmacokinetic Parameters Of Tyrosine Kinase Inhibitors Used In Chronic Myeloid Leukemia	0
OP10 Standardized Multilingual Reporting Of Health Technology Assessment And Stakeholder Involvement	0
EUnetHTA’s contribution to the new legal framework for health technology assessment cooperation in Europe	0
OP156 Systematic Review And Meta-Analysis Of The Perioperative Association Of Gabapentinoids With Sedation And Respiratory Depression After Abdominal Surgery	0
PD223 Early Dialogue With Researchers: The Case Of The OPTIBIO Study, Innovating From The Investigation Stages	0
PP61 A Decade Of Enhanced Patient And Citizen Involvement In Health Technology Appraisal In Scotland	0
PP45 Core Outcome Sets For Research And Core Outcome Sets For Routine Care: Do They Overlap?	0
A genuine need or nice to have? Understanding HTA representatives’ perspectives on the use of patient preference data	0
OP18 Laying The Foundation For Sustainable Health Technology Assessment Training Program In Ukraine	0
OP81 Experience Matters: A Discrete Choice Experiment Exploring Patient Preferences For Heart Valve Procedures	0
OP67 “Black Box Bottleneck” Paradigm And Transparency Issues On Artificial-Intelligence-Based Tools In Health Technology Assessment: A Scoping Review	0
OP24 Impact Of Patient Input On Cancer Drug Funding Recommendations In Canada	0
OP236 Evidence Synthesis Of Time-To-Event Outcomes In The Presence Of Non-Proportional Hazards	0
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies	0
Health technology assessment of medicinal products in Greece: a 5-year (2018–2023) review of timelines and productivity	0
PD135 Real-World Evidence On The Effects Of Robotic Prostatectomy In Poland	0
OP33 Advancing Patient Experience Data Implementation In Reimbursement Decision-Making: Insights On Challenges And Opportunities From Multistakeholder Interviews	0